Celltrion holdings Nasdaq

Corporate strategy Hankook & Company to set up CVC with $11 mn in funding

Hankook & Company Co., the holding company of Hankook Tire & Technology Co., announced Thursday a plan to launch a wholly owned corporate ve...

Bio & Pharma Celltrion unveils cancer medicine to expand new drug pipelines

South Korea’s leading biosimilar drug developer Celltrion Inc. on Sunday unveiled an anticancer medicine to expand new pipelines and accelerat...

Earnings S.Korea’s top 4 financial holding firms cheer upbeat Q1 results

South Korea’s top four financial holding companies – Shinhan, KB, Hana and Woori – reported stellar earnings for the first quarter...

Bio & Pharma Celltrion expands footprint in Latin America with flagship oncology drugs

South Korea’s biopharmaceutical giant Celltrion Inc. has solidified its presence in South America after winning supply contracts for its flags...

Bio & Pharma Celltrion wins Australian approval for eye, bone disease biosimilars

Celltrion Inc. said Wednesday it has received regulatory approval from Australia’s Therapeutic Goods Administration (TGA) for three biosimilar...

Business & Politics S.Korean President Yoon Suk Yeol ousted; new presidential election coming

South Korea’s Constitutional Court permanently removed President Yoon Suk Yeol from office on Friday, making him the country’s second pr...

Business & Politics S.Korean court to rule on impeached President Yoon’s fate April 4

South Korea’s Constitutional Court on Friday will give its ruling on President Yoon Suk Yeol, who was impeached in December for declaring mart...

Leadership & Management Hanwha gears up for 3rd-generation leadership with chairman’s stake gift

South Korea’s chemical-to-defense conglomerate Hanwha Group Chairman Kim Seung-youn will hand over half of his holdings in the conglomerate&rs...

Bio & Pharma Celltrion to sell autoimmune drug Stelara biosimilar at Costco in US

South Korea’s leading biosimilar drug developer Celltrion Inc. said on Monday it is set to sell Steqeyma, a biosimilar to autoimmune disease t...

Pension funds NPS to buy stake in Australia’s Metrics to expand alternative investments

South Korea’s National Pension Service (NPS), the world’s third-largest pension fund, has agreed to buy a stake in Australian asset mana...

Shareholder value Celltrion to cancel $140 mn in treasury shares, stock up

South Korea’s leading biosimilar drug developer Celltrion Inc. announced on Friday a plan to cancel $140 million worth of treasury shares to i...

Upcoming IPOs Hanwha Energy begins IPO process, key to 3rd-generation shift

Hanwha Energy Corp., wholly owned by Hanwha Group Chairman Kim Seung-youn’s three sons, has embarked on the process of going public – a ...

Webtoons Naver’s Webtoon hints at ad business expansion in 2025

Webtoon Entertainment Inc., the Nasdaq-listed storytelling platform operator under South Korea’s internet giant Naver Corp., is set to expand ...

Bio & Pharma Samsung, Celltrion lead biosimilar market in Europe, US

Samsung Bioepis Co. and Celltrion Inc. are outpacing long-established global drug manufacturers such as Amgen Inc. and Sandoz in the antibody biosim...

Private equity Affinity, GIC sell out of Kyobo Life; Chairman Shin seeks holding firm, M&A

Affinity Equity Partners and Singapore’s sovereign wealth fund GIC have sold their entire stake in Kyobo Life Insurance Co., exiting from thei...

Electronics LG Electronics hits record sales in India, paving way for 2025 IPO

LG Electronics Inc. posted its largest-ever sales in India in 2024, providing a boost to the planned initial public offering of its Indian unit this...

Bio & Pharma Celltrion wins EU approval for autoimmune disease treatment Avtozma

Celltrion Inc.’s Avtozma, a biosimilar to Roche’s autoimmune disease treatment Actemra, has won approval from the European Commission, f...

Stocks Meritz leaps to No. 2 financial holding firm in South Korea

Meritz Financial Group Inc., once a medium-sized financial service firm in South Korea, has become the second-most valuable publicly traded financia...

Stocks KKR recoups $206 mn in block sale of HD Hyundai Marine shares

Global private equity firm KKR & Co. Inc. has succeeded in cashing out of its stake in HD Hyundai Marine Solution Co. for 295 billion won ($206 ...

Earnings Meritz cheers record profit in 2024, boasts top 3 market cap

Meritz Financial Group Inc. has reported its best-ever net profit for last year thanks to handsome gains from investments by its insurance and secur...

Banking & Finance KB Financial to buy back $359 bn in shares after record net profit in 2024

KB Financial Group Inc., South Korea’s largest financial holding group, will spend nearly 1.8 trillion won ($1.2 billion) to boost shareholder...

Bio & Pharma Celltrion’s Vegzelma: Most-prescribed cancer treatment in Europe

South Korea’s leading biosimilar drug developer Celltrion Inc.'s Vegzelma, a cancer drug referencing global biopharma Roche’s Avastin, h...

Earnings Korean financial holding firms log record-high profits in 2024

South Korea’s top four financial holding firms are estimated to have posted their highest-ever profits in 2024, driven by hefty interest incom...

Airlines Sono Hospitality heralds proxy fight to control T’way Air

Sono Hospitality Group, South Korea’s top resort operator, has vowed to more actively horn in on the business of T'way Air Co., portending a p...

ESG Korea Investment Holdings’ MSCI ESG rating upgraded to A

Korea Investment Holdings Co. said on Thursday it was upgraded by three notches from B to A in the MSCI ESG rating this year.The MSCI ESG rating is ...

IPOs Celltrion seeks large-scale M&A in Q4, eyes 2027 Nasdaq debut

SAN FRANCISCO – South Korea’s leading biosimilar drug developer Celltrion Inc. seeks to acquire a domestic health food maker as early as...

IPOs Korean entertainment powerhouse K Wave Media to debut on Nasdaq in Feb

K Wave Media Ltd., an umbrella entity of South Korean entertainment companies, is set to go public on the Nasdaq next month in a bid to raise money ...

Corporate investment Mirae Asset invests $200 mn in LS Group affiliate in US

South Korea's Mirae Asset Global Investments said on Sunday it invested $200 million in Essex Solutions, a US magnet wire manufacturing affiliate un...

Bio & Pharma Korean drugmakers control more than half of European biosimilar market

South Korea’s two leading drugmakers, Celltrion Inc. and Samsung Bioepis Co., have achieved a significant milestone in the European biosimilar...

Corporate strategy POSCO Holdings unveils aggressive value-up plan, hike in cash dividends

South Korea’s steel-to-battery materials conglomerate POSCO Group on Monday unveiled a spate of corporate value-up measures, including a highe...